Segall Bryant & Hamill’s Invacare Corporation IVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-98,056
Closed -$729K 833
2020
Q1
$729K Buy
98,056
+15,010
+18% +$116K 0.01% 505
2019
Q4
$749K Sell
83,046
-24,922
-23% -$210K 0.01% 583
2019
Q3
$810K Sell
107,968
-5,321
-5% -$29.8K 0.01% 557
2019
Q2
$588K Buy
113,289
+40,545
+56% +$264K 0.01% 636
2019
Q1
$609K Sell
72,744
-2,336
-3% -$16.8K 0.01% 630
2018
Q4
$323K Buy
75,080
+22,064
+42% +$195K 0.01% 723
2018
Q3
$771K Buy
53,016
+17,047
+47% +$282K 0.01% 600
2018
Q2
$669K Buy
+35,969
New +$651K 0.01% 615

Other funds holding IVC

Segall Bryant & Hamill's IVC Position: Q2 2020 in Review

Segall Bryant & Hamill sold out of Invacare Corporation (IVC) in Q2 2020, closing a stake of 98,056 shares — an estimated $729K sold.

Segall Bryant & Hamill first reported a position in IVC in Q2 2018 and held it in 8 quarters. The position peaked at $810K in Q3 2019. 140 funds tracked by Wall St. Rank hold IVC as of Q2 2020.

  • Segall Bryant & Hamill reported no remaining Invacare Corporation position as of Q2 2020 after selling out during the quarter.
  • Segall Bryant & Hamill sold 98,056 Invacare Corporation shares in Q2 2020, an estimated $729K.
  • Segall Bryant & Hamill first reported a position in Invacare Corporation in Q2 2018 and held it in 8 quarters.
  • Segall Bryant & Hamill's Invacare Corporation position peaked at $810K in Q3 2019.
  • 140 funds tracked by Wall St. Rank held Invacare Corporation as of Q2 2020.

Based on Segall Bryant & Hamill's 13F filing for Q2 2020, filed 14 Aug 2020.